GLOW Blend (CU + BPC + TB)
For Research Use Only. Not for human or veterinary use.
Product Overview
GLOW Blend is a research combination formulation containing three peptide compounds: GHK-Cu (copper peptide), BPC-157, and TB-500 (Thymosin Beta-4 fragment). This multi-component research blend is designed for laboratory studies investigating synergistic interactions among copper-chelating, gastrointestinal-derived, and actin-modulating peptides in tissue repair and regenerative biology research models. This research-grade lyophilized material is supplied exclusively for in-vitro and laboratory investigation.
Specifications
| Parameter | Specification |
|---|---|
| Product Name | GLOW Blend (GHK-Cu + BPC-157 + TB-500) |
| CAS Number | Available upon request |
| Molecular Formula | Available in COA |
| Molecular Weight | See COA |
| Purity | ≥99% (HPLC) |
| Appearance | White lyophilized powder |
| Packaging | 70mg × 10 vials |
| Storage | -20°C, protect from light |
Research Background
GHK-Cu (glycyl-L-histidyl-L-lysine:copper(II)) is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine. Research has investigated its role in copper transport and its reported capacity to modulate extracellular matrix remodeling through regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). Published cell culture studies have examined GHK-Cu’s effects on collagen and glycosaminoglycan synthesis in fibroblast models, as well as gene expression changes associated with tissue remodeling and antioxidant defense pathways.
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in human gastric juice. Research in rodent models has extensively examined this compound in gastrointestinal mucosal protection studies, tendon and ligament repair models, and angiogenesis assays. Published studies have investigated its effects on nitric oxide (NO) synthesis pathways and vascular endothelial growth factor (VEGF) expression in endothelial cell models, contributing to research on peptide-mediated modulation of vascular biology.
TB-500, a synthetic fragment of the ubiquitous actin-sequestering protein Thymosin Beta-4, has been studied for its role in G-actin binding and the regulation of cell motility and migration. Research in endothelial and keratinocyte cell models has examined TB-500’s reported effects on angiogenic sprouting and wound-edge cell migration assays. The GLOW combination is employed in research settings to investigate whether co-application of these three complementary peptides produces measurable synergistic or additive effects compared to individual compound controls in regenerative biology assays.
Quality Control
- HPLC purity verification (≥99%)
- Mass spectrometry identity confirmation
- Endotoxin tested
- Certificate of Analysis (COA) provided per lot
- Batch traceability maintained
Handling & Storage
Store unopened lyophilized powder at -20°C. After reconstitution with bacteriostatic or sterile water, store at 2–8°C and use within recommended stability window. Avoid repeated freeze-thaw cycles. Material should only be handled by trained laboratory personnel using appropriate PPE and within validated research workflows.
Bulk & Custom Orders
Glunova Biotech LLC supplies research institutions, universities, and contract research organizations worldwide. For bulk pricing, custom packaging, or supply agreements, contact dylan.tom2012@gmail.com.
Safety Data Sheet (SDS)
SDS for this product is currently in preparation. For interim safety documentation, hazard classification, or handling guidance, contact dylan.tom2012@gmail.com. We provide preliminary safety data within 1 business day to verified research institutions.
This product is sold strictly for laboratory research purposes. It is not a drug, food, cosmetic, or dietary supplement. It is not approved by the FDA for human or veterinary use. Resale or transfer for non-research applications is prohibited.